Notifiable Share Interest in OctoPlus N.V.

RNS Number : 4104S

GlaxoSmithKline PLC

18 November 2011

 



 Notifiable Share Interest in OctoPlus N.V.

GlaxoSmithKline plc ("GSK") announces that following a private placement offering made by OctoPlus N.V. ("OctoPlus"), a pharmaceuticals product and drug delivery company located in the Netherlands and whose shares are traded on Euronext Amsterdam, on 26 October 2011, GSK's interest in Octoplus has decreased.

GSK's interest, which is held by S.R. One, Limited,a wholly owned US-registered subsidiary of GSK ("S.R.One"), now comprises 4,345,062 ordinary shares or 9.7% of OctoPlus. The calculation is based on a total of 44,778,974 shares outstanding in OctoPlus.  This decreased interest became disclosable under the rules of the Dutch Financial Supervision Act upon falling below 10% of the issued share capital of OctoPlus, and a notification regarding this decreased holding is due to be made to the Netherlands Authority for the Financial Markets ("AFM") on 18 November 2011.

Victoria Whyte

Company Secretary

18 November 2011

 

END

 

 

HOLUWABRANAAAAA